sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Biotechnology / ADME Toxicology Testing

ADME Toxicology Testing Market By Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Other Toxicities), By Method (Cellular Assay, Biochemical Assay, In-Silica, and Ex-Vivo), and By End-User (Cosmetics & Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026

  • Publish On: Jun-2021
  • Total Pages: 196
  • Report Code: FAF-1495
  • Base Year: 2020
  • Format:

Industry Insights

[196+ Pages Report] The global ADME toxicology testing market is set for rapid growth over the forecast period. In terms of revenue, the global ADME toxicology testing market accounted for USD 5.4 Billion in 2020 and is anticipated to reach around USD 11.4 Billion by 2026, growing at a CAGR of 11.4%.

Global ADME Toxicology Testing Market: Overview

ADME toxicology testing is primarily used to perform pharmacological, chemical, and genetic experiments and tests that assist in the drug development process, from drug formulation to drug trials and other drug interactions. Various liquid-handling instruments, control software, and other detectors are used in this method to quickly distinguish genetic interactions, active compounds, and other biomolecular interactions.

Global ADME Toxicology Testing Market: Growth Factors

The growth of the ADME toxicology testing market can be attributed to the growing number of drug designs and the increasing demand from biotechnology and pharmaceutical companies due to the reduced cost of various tests that are required during drug development. Also, factors such as reduced time required for commercialization of drug lower number of failures during drug development are also expected to drive the market growth. To avoid late-stage failure and ensure systematic assessment, ADME toxicology monitoring is now performed during the drug design and production process. To meet regulatory requirements, most businesses use GLP and non-GLP testing methods. To achieve consistency and authenticity of collected and processed data, regulatory bodies are being urged to define stricter quality control requirements. However, the market's growth is expected to be hampered by a shortage of effective software to manage liquid handling systems and automated robotic arms. Regulatory reforms by regulatory bodies such as the FDA in the United States are expected to have an effect on the industry and the manner in which technologies are pursued. For example, few FDA departments have requested that businesses do ADME toxicology tests on animals in the same disease state as humans, in order to draw a straight distinction between real-time outcomes from the near condition and results from normal animals. In addition, owing to the widespread outbreak of coronavirus disease (COVID-19) and the absence of an appropriate vaccine or cure, ADME toxicology testing is being used to measure the efficacy of existing medications as a potential treatment, which is boosting market development. Over the forecast period, the global ADME toxicology testing industry is expected to expand at a rapid pace.

Global ADME Toxicology Testing Market: Segmentation

The global ADME toxicology testing market is divided into its technology, application, method, end-user, and regions. Based on technology, the global market is divided into molecular imaging, cell culture, OMICS technology, and high throughput. The cell culture category in technology segmentation dominated the technology segmentation in 2019 with market share of around 40% and is expected to continue its dominance in upcoming years. The dominance of the cell culture category can be attributed to the emergence of assays using the fluorometric imaging plate reader (FLIPR) and their capability to test small volumes. Ultra ADME toxicology testing is the most recent innovation in the industry, resulting in higher productivity in less time. Many businesses are in the process of transitioning from conventional 2D to 3D cell cultures. Based on the application, the global market is divided into renal toxicity, neurotoxicity, systemic toxicity, hepatotoxicity, and other toxicities. The systemic toxicity category in application segmentation dominated the application segmentation in 2019 with market share of around 70% and is expected to continue its dominance in upcoming years. This can be attributed to the popularity of systemic circulation as one of the most chosen methods for drug distribution. The renal toxicity category is expected to grow at a healthy rate in the forecast period due to new studies and active researches that are being presently carried out in the industry hence registering a growth rate more than systemic toxicity. Based on the method, the market is divided into biochemical assay, ex-vivo, cellular assay, and in-silica. Based on the end-user, the market is divided into food industry, pharmaceutical industry, animal industry, cosmetics & household products, and others. Geographically, the global market is divided into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Global ADME Toxicology Testing Market: Regional Analysis

The North America region dominated the global ADME toxicology testing market in 2019 with a market share of around 45% and is anticipated to continue its dominance in the forecast period. The dominance of the North America region can be attributed to the current as well as upcoming technological advancements in the new drug molecule development especially in the drug discovery with the help of cell cultures. In addition, one of the major industry developments is the Food and Drug Administration's (FDA) introduction of multiple guidance documents that offer instruction on ADME properties when assessing the efficacy and safety of a drug candidate. Apart from that, software that calculates ADME automatically is gaining popularity as an alternative to traditional in vivo and in vitro experiments.

The Asia Pacific region is anticipated to grow at a significant rate in the upcoming years attributed to the adoption of new technologies by countries such as Japan, India, China, and South Korea in order to improve the medical standards. Also, the increasing efforts by countries such as Japan and China for developing newer pharmaceutical molecules are expected to drive the growth of the region in the forecast period.

Global ADME Toxicology Testing Market: Competitive Players

Some of the key players in the market are Thermo Fisher Scientific Inc., Promega Corporation, Beckman Coulter, Inc., (Danaher), Albany Molecular Research Inc., Eurofins Scientific SE, Life Technologies Corporation, Quintiles, Agilent Technologies, Accelrys, Inc., (Dassault Systemes BIOVIA), Catalent, Covance, Inc. (LabCorp), Charles River Laboratories International, Inc., General Electric Company (Healthcare), and Miltenyi Biotec among others. 

Global ADME Toxicology Testing Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle-East Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of ADME Toxicology Testing
    2. 1.2. Global ADME Toxicology Testing Market, 2020 & 2026 (USD Million)
    3. 1.3. Global ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 1.4. Global ADME Toxicology Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global ADME Toxicology Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 ADME Toxicology Testing Market – Technology Analysis
    1. 2.1. Global ADME Toxicology Testing Market – Technology Overview
    2. 2.2. Global ADME Toxicology Testing Market Share, by Technology, 2020 & 2026 (USD Million)
    3. 2.3. Cell Culture
      1. 2.3.1. Global Cell Culture ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 2.4. High Throughput
      1. 2.4.1. Global High Throughput ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    5. 2.5. Molecular Imaging
      1. 2.5.1. Global Molecular Imaging ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    6. 2.6. OMICS Technology
      1. 2.6.1. Global OMICS Technology ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
  3. Chapter 3 ADME Toxicology Testing Market – Application Analysis
    1. 3.1. Global ADME Toxicology Testing Market – Application Overview
    2. 3.2. Global ADME Toxicology Testing Market Share, by Application, 2020 & 2026 (USD Million)
    3. 3.3. Systemic Toxicity
      1. 3.3.1. Global Systemic Toxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 3.4. Renal Toxicity
      1. 3.4.1. Global Renal Toxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    5. 3.5. Hepatotoxicity
      1. 3.5.1. Global Hepatotoxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    6. 3.6. Neurotoxicity
      1. 3.6.1. Global Neurotoxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    7. 3.7. Other Toxicities
      1. 3.7.1. Global Other Toxicities ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
  4. Chapter 4 ADME Toxicology Testing Market – Method Analysis
    1. 4.1. Global ADME Toxicology Testing Market – Method Overview
    2. 4.2. Global ADME Toxicology Testing Market Share, by Method, 2020 & 2026 (USD Million)
    3. 4.3. Cellular Assay
      1. 4.3.1. Global Cellular Assay ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 4.4. Biochemical Assay
      1. 4.4.1. Global Biochemical Assay ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    5. 4.5. In-Silica
      1. 4.5.1. Global In-Silica ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    6. 4.6. Ex-Vivo
      1. 4.6.1. Global Ex-Vivo ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
  5. Chapter 5 ADME Toxicology Testing Market – End-User Analysis
    1. 5.1. Global ADME Toxicology Testing Market – End-User Overview
    2. 5.2. Global ADME Toxicology Testing Market Share, by End-User, 2020 & 2026 (USD Million)
    3. 5.3. Cosmetics & Household Products
      1. 5.3.1. Global Cosmetics & Household Products ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 5.4. Pharmaceutical Industry
      1. 5.4.1. Global Pharmaceutical Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    5. 5.5. Animal Industry
      1. 5.5.1. Global Animal Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    6. 5.6. Food Industry
      1. 5.6.1. Global Food Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    7. 5.7. Others
      1. 5.7.1. Global Others ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
  6. Chapter 6 ADME Toxicology Testing Market – Regional Analysis
    1. 6.1. Global ADME Toxicology Testing Market Regional Overview
    2. 6.2. Global ADME Toxicology Testing Market Share, by Region, 2020 & 2026 (USD Million)
    3. 6.3. North America
      1. 6.3.1. North America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
        1. 6.3.1.1. North America ADME Toxicology Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 6.3.2. North America ADME Toxicology Testing Market, by Technology, 2016 – 2026
        1. 6.3.2.1. North America ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      3. 6.3.3. North America ADME Toxicology Testing Market, by Application, 2016 – 2026
        1. 6.3.3.1. North America ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      4. 6.3.4. North America ADME Toxicology Testing Market, by Method, 2016 – 2026
        1. 6.3.4.1. North America ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      5. 6.3.5. North America ADME Toxicology Testing Market, by End-User, 2016 – 2026
        1. 6.3.5.1. North America ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      6. 6.3.6. U.S.
        1. 6.3.6.1. U.S. ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      7. 6.3.7. Canada
        1. 6.3.7.1. Canada ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    4. 6.4. Europe
      1. 6.4.1. Europe ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
        1. 6.4.1.1. Europe ADME Toxicology Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 6.4.2. Europe ADME Toxicology Testing Market, by Technology, 2016 – 2026
        1. 6.4.2.1. Europe ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      3. 6.4.3. Europe ADME Toxicology Testing Market, by Application, 2016 – 2026
        1. 6.4.3.1. Europe ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      4. 6.4.4. Europe ADME Toxicology Testing Market, by Method, 2016 – 2026
        1. 6.4.4.1. Europe ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      5. 6.4.5. Europe ADME Toxicology Testing Market, by End-User, 2016 – 2026
        1. 6.4.5.1. Europe ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      6. 6.4.6. Germany
        1. 6.4.6.1. Germany ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      7. 6.4.7. France
        1. 6.4.7.1. France ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      8. 6.4.8. U.K.
        1. 6.4.8.1. U.K. ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      9. 6.4.9. Italy
        1. 6.4.9.1. Italy ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      10. 6.4.10. Spain
        1. 6.4.10.1. Spain ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      11. 6.4.11. Rest of Europe
        1. 6.4.11.1. Rest of Europe ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
        1. 6.5.1.1. Asia Pacific ADME Toxicology Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 6.5.2. Asia Pacific ADME Toxicology Testing Market, by Technology, 2016 – 2026
        1. 6.5.2.1. Asia Pacific ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      3. 6.5.3. Asia Pacific ADME Toxicology Testing Market, by Application, 2016 – 2026
        1. 6.5.3.1. Asia Pacific ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      4. 6.5.4. Asia Pacific ADME Toxicology Testing Market, by Method, 2016 – 2026
        1. 6.5.4.1. Asia Pacific ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      5. 6.5.5. Asia Pacific ADME Toxicology Testing Market, by End-User, 2016 – 2026
        1. 6.5.5.1. Asia Pacific ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      6. 6.5.6. China
        1. 6.5.6.1. China ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      7. 6.5.7. Japan
        1. 6.5.7.1. Japan ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      8. 6.5.8. India
        1. 6.5.8.1. India ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      9. 6.5.9. South Korea
        1. 6.5.9.1. South Korea ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      10. 6.5.10. South-East Asia
        1. 6.5.10.1. South-East Asia ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      11. 6.5.11. Rest of Asia Pacific
        1. 6.5.11.1. Rest of Asia Pacific ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    6. 6.6. Latin America
      1. 6.6.1. Latin America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
        1. 6.6.1.1. Latin America ADME Toxicology Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 6.6.2. Latin America ADME Toxicology Testing Market, by Technology, 2016 – 2026
        1. 6.6.2.1. Latin America ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      3. 6.6.3. Latin America ADME Toxicology Testing Market, by Application, 2016 – 2026
        1. 6.6.3.1. Latin America ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      4. 6.6.4. Latin America ADME Toxicology Testing Market, by Method, 2016 – 2026
        1. 6.6.4.1. Latin America ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      5. 6.6.5. Latin America ADME Toxicology Testing Market, by End-User, 2016 – 2026
        1. 6.6.5.1. Latin America ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      6. 6.6.6. Brazil
        1. 6.6.6.1. Brazil ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      7. 6.6.7. Mexico
        1. 6.6.7.1. Mexico ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      8. 6.6.8. Rest of Latin America
        1. 6.6.8.1. Rest of Latin America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
    7. 6.7. The Middle-East and Africa
      1. 6.7.1. The Middle-East and Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
        1. 6.7.1.1. The Middle-East and Africa ADME Toxicology Testing Market, by Country, 2016 - 2026 (USD Million)
      2. 6.7.2. The Middle-East and Africa ADME Toxicology Testing Market, by Technology, 2016 – 2026
        1. 6.7.2.1. The Middle-East and Africa ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      3. 6.7.3. The Middle-East and Africa ADME Toxicology Testing Market, by Application, 2016 – 2026
        1. 6.7.3.1. The Middle-East and Africa ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      4. 6.7.4. The Middle-East and Africa ADME Toxicology Testing Market, by Method, 2016 – 2026
        1. 6.7.4.1. The Middle-East and Africa ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      5. 6.7.5. The Middle-East and Africa ADME Toxicology Testing Market, by End-User, 2016 – 2026
        1. 6.7.5.1. The Middle-East and Africa ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      6. 6.7.6. GCC Countries
        1. 6.7.6.1. GCC Countries ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      7. 6.7.7. South Africa
        1. 6.7.7.1. South Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      8. 6.7.8. Rest of Middle-East Africa
        1. 6.7.8.1. Rest of Middle-East Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
  7. Chapter 7 ADME Toxicology Testing Market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Developments
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. Chapter 8 Company Profiles
    1. 8.1. Thermo Fisher Scientific Inc.
      1. 8.1.1. Company Overview
      2. 8.1.2. Product/Service Portfolio
      3. 8.1.3. Thermo Fisher Scientific Inc. Sales, Revenue, and Gross Margin
      4. 8.1.4. Thermo Fisher Scientific Inc. Revenue and Growth Rate
      5. 8.1.5. Thermo Fisher Scientific Inc. Market Share
      6. 8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 8.2. Promega Corporation
      1. 8.2.1. Company Overview
      2. 8.2.2. Product/Service Portfolio
      3. 8.2.3. Promega Corporation Sales, Revenue, and Gross Margin
      4. 8.2.4. Promega Corporation Revenue and Growth Rate
      5. 8.2.5. Promega Corporation Market Share
      6. 8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 8.3. Agilent Technologies
      1. 8.3.1. Company Overview
      2. 8.3.2. Product/Service Portfolio
      3. 8.3.3. Agilent Technologies Sales, Revenue, and Gross Margin
      4. 8.3.4. Agilent Technologies Revenue and Growth Rate
      5. 8.3.5. Agilent Technologies Market Share
      6. 8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 8.4. Albany Molecular Research Inc.
      1. 8.4.1. Company Overview
      2. 8.4.2. Product/Service Portfolio
      3. 8.4.3. Albany Molecular Research Inc. Sales, Revenue, and Gross Margin
      4. 8.4.4. Albany Molecular Research Inc. Revenue and Growth Rate
      5. 8.4.5. Albany Molecular Research Inc. Market Share
      6. 8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 8.5. Accelrys, Inc., (Dassault Systemes BIOVIA)
      1. 8.5.1. Company Overview
      2. 8.5.2. Product/Service Portfolio
      3. 8.5.3. Accelrys, Inc., (Dassault Systemes BIOVIA) Sales, Revenue, and Gross Margin
      4. 8.5.4. Accelrys, Inc., (Dassault Systemes BIOVIA) Revenue and Growth Rate
      5. 8.5.5. Accelrys, Inc., (Dassault Systemes BIOVIA) Market Share
      6. 8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 8.6. Beckman Coulter, Inc., (Danaher)
      1. 8.6.1. Company Overview
      2. 8.6.2. Product/Service Portfolio
      3. 8.6.3. Beckman Coulter, Inc., (Danaher) Sales, Revenue, and Gross Margin
      4. 8.6.4. Beckman Coulter, Inc., (Danaher) Revenue and Growth Rate
      5. 8.6.5. Beckman Coulter, Inc., (Danaher) Market Share
      6. 8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 8.7. Catalent
      1. 8.7.1. Company Overview
      2. 8.7.2. Product/Service Portfolio
      3. 8.7.3. Catalent Sales, Revenue, and Gross Margin
      4. 8.7.4. Catalent Revenue and Growth Rate
      5. 8.7.5. Catalent Market Share
      6. 8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 8.8. Charles River Laboratories International, Inc.
      1. 8.8.1. Company Overview
      2. 8.8.2. Product/Service Portfolio
      3. 8.8.3. Charles River Laboratories International, Inc. Sales, Revenue, and Gross Margin
      4. 8.8.4. Charles River Laboratories International, Inc. Revenue and Growth Rate
      5. 8.8.5. Charles River Laboratories International, Inc. Market Share
      6. 8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 8.9. Covance, Inc. (LabCorp)
      1. 8.9.1. Company Overview
      2. 8.9.2. Product/Service Portfolio
      3. 8.9.3. Covance, Inc. (LabCorp) Sales, Revenue, and Gross Margin
      4. 8.9.4. Covance, Inc. (LabCorp) Revenue and Growth Rate
      5. 8.9.5. Covance, Inc. (LabCorp) Market Share
      6. 8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 8.10. Eurofins Scientific SE
      1. 8.10.1. Company Overview
      2. 8.10.2. Product/Service Portfolio
      3. 8.10.3. Eurofins Scientific SE Sales, Revenue, and Gross Margin
      4. 8.10.4. Eurofins Scientific SE Revenue and Growth Rate
      5. 8.10.5. Eurofins Scientific SE Market Share
      6. 8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 8.11. General Electric Company (Healthcare)
      1. 8.11.1. Company Overview
      2. 8.11.2. Product/Service Portfolio
      3. 8.11.3. General Electric Company (Healthcare) Sales, Revenue, and Gross Margin
      4. 8.11.4. General Electric Company (Healthcare) Revenue and Growth Rate
      5. 8.11.5. General Electric Company (Healthcare) Market Share
      6. 8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 8.12. Life Technologies Corporation
      1. 8.12.1. Company Overview
      2. 8.12.2. Product/Service Portfolio
      3. 8.12.3. Life Technologies Corporation Sales, Revenue, and Gross Margin
      4. 8.12.4. Life Technologies Corporation Revenue and Growth Rate
      5. 8.12.5. Life Technologies Corporation Market Share
      6. 8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 8.13. Miltenyi Biotec
      1. 8.13.1. Company Overview
      2. 8.13.2. Product/Service Portfolio
      3. 8.13.3. Miltenyi Biotec Sales, Revenue, and Gross Margin
      4. 8.13.4. Miltenyi Biotec Revenue and Growth Rate
      5. 8.13.5. Miltenyi Biotec Market Share
      6. 8.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 8.14. Quintiles
      1. 8.14.1. Company Overview
      2. 8.14.2. Product/Service Portfolio
      3. 8.14.3. Quintiles Sales, Revenue, and Gross Margin
      4. 8.14.4. Quintiles Revenue and Growth Rate
      5. 8.14.5. Quintiles Market Share
      6. 8.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  9. Chapter 9 ADME Toxicology Testing — Industry Analysis
    1. 9.1. Introduction and Taxonomy
    2. 9.2. ADME Toxicology Testing Market – Key Trends
      1. 9.2.1. Market Drivers
      2. 9.2.2. Market Restraints
      3. 9.2.3. Market Opportunities
    3. 9.3. Value Chain Analysis
    4. 9.4. Key Mandates and Regulations
    5. 9.5. Technology Roadmap and Timeline
    6. 9.6. ADME Toxicology Testing Market – Attractiveness Analysis
      1. 9.6.1. By Technology
      2. 9.6.2. By Application
      3. 9.6.3. By Method
      4. 9.6.4. By End-User
      5. 9.6.5. By Region
  10. Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 10.1. ADME Toxicology Testing Industrial Chain Analysis
    2. 10.2. Downstream Buyers
    3. 10.3. Distributors/Traders List
  11. Chapter 11 Marketing Strategy Analysis
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trends
    5. 11.5. Economic/Political Environmental Change
  12. Chapter 12 Report Conclusion & Key Insights
    1. 12.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  13. Chapter 13 Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Statistical Models
        1. 13.3.3.1. Company Share Analysis Model
        2. 13.3.3.2. Revenue Based Modeling
      4. 13.3.4. Research Limitations 

      List of Figures

      Fig.1	Product Picture of ADME Toxicology Testing
      Fig.2	Global ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.3	Global ADME Toxicology Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global ADME Toxicology Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global ADME Toxicology Testing Market Share, by Technology, 2020 & 2026 (USD Million)
      Fig.6	Global Cell Culture ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.7	Global High Throughput ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.8	Global Molecular Imaging ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.9	Global OMICS Technology ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.10	Global ADME Toxicology Testing Market Share, by Application, 2020 & 2026 (USD Million)
      Fig.11	Global Systemic Toxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.12	Global Renal Toxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.13	Global Hepatotoxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.14	Global Neurotoxicity ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.15	Global Other Toxicities ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.16	Global ADME Toxicology Testing Market Share, by Method, 2020 & 2026 (USD Million)
      Fig.17	Global Cellular Assay ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.18	Global Biochemical Assay ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.19	Global In-Silica ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.20	Global Ex-Vivo ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.21	Global ADME Toxicology Testing Market Share, by End-User, 2020 & 2026 (USD Million)
      Fig.22	Global Cosmetics & Household Products ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.23	Global Pharmaceutical Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.24	Global Animal Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.25	Global Food Industry ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.26	Global Others ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.27	Global ADME Toxicology Testing Market Share, by Region, 2020 & 2026 (USD Million)
      Fig.28	North America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.29	U.S. ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.30	Canada ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.31	Europe ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.32	Germany ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.33	France ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.34	U.K. ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.35	Italy ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.36	Spain ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.37	Rest of Europe ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.38	Asia Pacific ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.39	China ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.40	Japan ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.41	India ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.42	South  Korea ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.43	South-East Asia ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.44	Rest of Asia Pacific ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.45	Latin America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.46	Brazil ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.47	Mexico ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.48	Rest of Latin America ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.49	The Middle-East and Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.50	GCC Countries ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.51	South Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.52	Rest of Middle-East Africa ADME Toxicology Testing Market, 2016 – 2026 (USD Million)
      Fig.53	Competitor Market Share – Revenue
      Fig.54	Thermo Fisher Scientific Inc. Revenue and Growth Rate
      Fig.55	Thermo Fisher Scientific Inc. Market Share
      Fig.56	Promega Corporation Revenue and Growth Rate
      Fig.57	Promega Corporation Market Share
      Fig.58	Agilent Technologies Revenue and Growth Rate
      Fig.59	Agilent Technologies Market Share
      Fig.60	Albany Molecular Research Inc. Revenue and Growth Rate
      Fig.61	Albany Molecular Research Inc. Market Share
      Fig.62	Accelrys, Inc., (Dassault Systemes BIOVIA) Revenue and Growth Rate
      Fig.63	Accelrys, Inc., (Dassault Systemes BIOVIA) Market Share
      Fig.64	Beckman Coulter, Inc., (Danaher) Revenue and Growth Rate
      Fig.65	Beckman Coulter, Inc., (Danaher) Market Share
      Fig.66	Catalent Revenue and Growth Rate
      Fig.67	Catalent Market Share
      Fig.68	Charles River Laboratories International, Inc. Revenue and Growth Rate
      Fig.69	Charles River Laboratories International, Inc. Market Share
      Fig.70	Covance, Inc. (LabCorp) Revenue and Growth Rate
      Fig.71	Covance, Inc. (LabCorp) Market Share
      Fig.72	Eurofins Scientific SE Revenue and Growth Rate
      Fig.73	Eurofins Scientific SE Market Share
      Fig.74	General Electric Company (Healthcare) Revenue and Growth Rate
      Fig.75	General Electric Company (Healthcare) Market Share
      Fig.76	Life Technologies Corporation Revenue and Growth Rate
      Fig.77	Life Technologies Corporation Market Share
      Fig.78	Miltenyi Biotec Revenue and Growth Rate
      Fig.79	Miltenyi Biotec Market Share
      Fig.80	Quintiles Revenue and Growth Rate
      Fig.81	Quintiles Market Share
      Fig.82	Market Dynamics
      Fig.83	Global ADME Toxicology Testing – Value Chain Analysis
      Fig.84	Key Mandates and Regulations
      Fig.85	Technology Roadmap and Timeline
      Fig.86	Market Attractiveness Analysis – By Technology
      Fig.87	Market Attractiveness Analysis – By Application
      Fig.88	Market Attractiveness Analysis – By Method
      Fig.89	Market Attractiveness Analysis – By End-User
      Fig.90	Market Attractiveness Analysis – By Region
      Fig.91	ADME Toxicology Testing Industrial Chain Analysis
      Fig.92	Market Channels
      Fig.93	Marketing Channel Development Trend
      Fig.94	Growth in World Gross Product, 2008-2018 
      

      List of Tables

      Table 1	Global ADME Toxicology Testing Market, 2020 & 2026 (USD Million)
      Table 2	Global ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 3	Global ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 4	Global ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 5	Global ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 6	Global ADME Toxicology Testing Market, by Region, 2016 – 2026 (USD Million)
      Table 7	North America ADME Toxicology Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 8	North America ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 9	North America ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 10 North America ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 11 North America ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 12 Europe ADME Toxicology Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 13 Europe ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 14 Europe ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 15 Europe ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 16 Europe ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific ADME Toxicology Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 18 Asia Pacific ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 19 Asia Pacific ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 20 Asia Pacific ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 21 Asia Pacific ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 22 Latin America ADME Toxicology Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 23 Latin America ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 24 Latin America ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 25 Latin America ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 26 Latin America ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 27 The Middle-East and Africa ADME Toxicology Testing Market, by Country, 2016 – 2026 (USD Million)
      Table 28 The Middle-East and Africa ADME Toxicology Testing Market, by Technology, 2016 – 2026 (USD Million)
      Table 29 The Middle-East and Africa ADME Toxicology Testing Market, by Application, 2016 – 2026 (USD Million)
      Table 30 The Middle-East and Africa ADME Toxicology Testing Market, by Method, 2016 – 2026 (USD Million)
      Table 31 The Middle-East and Africa ADME Toxicology Testing Market, by End-User, 2016 – 2026 (USD Million)
      Table 32 Global ADME Toxicology Testing Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 33 Global ADME Toxicology Testing Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 34 Acquisitions and Mergers
      Table 35 Market Drivers – Impact Analysis
      Table 36 Market Restraints
      Table 37 Market Opportunities
      Table 38 Major Buyers of ADME Toxicology Testing
      Table 39 Distributors/Traders of ADME Toxicology Testing by Region
      

Industry Major Market Players

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Beckman Coulter Inc.(Danaher)
  • Albany Molecular Research Inc.
  • Eurofins Scientific SE
  • Life Technologies Corporation
  • Quintiles
  • Agilent Technologies
  • Accelrys Inc.
  • (Dassault Systemes BIOVIA)
  • Catalent
  • Covance Inc. (LabCorp)
  • Charles River Laboratories International Inc.
  • General Electric Company (Healthcare)
  • Miltenyi Biotec 

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions